References (Continued, Page 3)

Hultman, C. M., Ohman, A., Cnattingius, S., Wieselgren, I. M., & Lindstrom, L. H. (1997). Prenatal and neonatal risk factors for schizophrenia. British Journal of Psychiatry, 170, 128–133.

Inayama, Y., Yoneda, H., Sakai, T., Ishida, T., Nonomura, Y., Kono, Y., Takahata, R., Koh, J., Sakai, J., Takai, A., Inada, Y., & Asaba, H. (1996). Positive association between a DNA sequence variant in the serotonin 2A receptor gene and schizophrenia. American Journal of Medical Genetics, 67, 103–105.

Ingram, R. E., Miranda, J., & Segal, Z. V. (1998). Cognitive vulnerability to depression. New York: Guilford Press.

Institute of Medicine (1994). Reducing risks for mental disorders: Frontiers for preventive intervention research. Washington, DC: National Academy Press.

Institute of Medicine (1995). Development of medications for the treatment of opiate and cocaine addictions: Issues for the government and private sector. Washington, DC: National Academy Press.

Institute of Medicine. (1996). Understanding violence against women. Washington, DC: National Academy Press.

Institute of Medicine (1998). Violence in families: Assessing prevention and treatment programs. Washington, DC: National Academy Press.

Iwahashi, K., Watanabe, M., Nakamura, K., Suwaki, H., Nakaya, T., Nakamura, Y., Takahashi, H., & Ikuta, K. (1998). Positive and negative syndromes, and Borna disease virus infection in schizophrenia. Neuropsychobiology, 37, 59–64.

Jablensky, A., Sartorius, N., Ernberg, G., Anker, M., Korten, A., Cooper, J. E., Day, R., & Bertelsen, A. (1992). Schizophrenia: Manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychological Medicine Monograph Supplement, 20, 1–97.

Jacobson, L., & Sapolsky, R. (1991). The role of the hippocampus in feedback regulation of the hypothalmic-pituitary-adrenocortical axis. Endocrine Reviews, 12, 118–134.

Jakob, H., & Beckmann, H. (1986). Prenatal developmental disturbances in the limbic allocortex in schizophrenics. Journal of Neural Transmission, 65, 303–326.

Janicak, P. G., Davis, J. M., Gibbons, R. D., Ericksen, S., Chang, S., & Gallagher, P. (1985). Efficacy of ECT: A meta-analysis. American Journal of Psychiatry, 142, 297–302.

Janicak, P. G., Newman, R. M., & Davis, J. M. (1992). Psychopharmacology update: Advances in the treatment of mania and related disorders: A reappraisal. Psychiatric Annals, 22, 92–103.

Janicak, P. G., Sharma, R. P., Pandey, G., & Davis, J. M. (1998). Verapamil for the treatment of acute mania: A double-blind, placebo-controlled trial. American Journal of Psychiatry, 155, 972–973.

Jann, M. W., Chang, W. H., Lam, Y. W., Hwu, H. G., Lin, H. N., Chen, H., Chen, T. Y., Lin, S. K., Chien, C. P., Davis, C. M., Ereshefsky, L., Sakland, S. R., Richards, A. L., & Shulteis, W. M. (1992). Comparison of haloperidol and reduced haloperidol plasma levels in four different ethnic populations. Progress in Neuro- Psychopharmacology and Biological Psychiatry, 16, 193–202.

Jenkins, J. H., & Karno, M. (1992). The meaning of expressed emotion: Theoretical issues raised by cross-cultural research. American Journal of Psychiatry, 149, 9–21.

Jensen, L. H., & Kane, C. F. (1996). Cognitive theory applied to the treatment of delusions of schizophrenia. Archives of Psychiatric Nursing, 10, 335B341.

Jeste, D. V., Gladsjo, J. A., Lindamer, L. A., & Lacro, J. P. (1996). Medical comorbidity in schizophrenia. Schizophrenia Bulletin, 22, 413–430.

Jones, P. B., & Cannon, M. (1998). The new epidemiology of schizophrenia. Psychiatric Clinics of North America, 21, 1–25.

Jones, P. B., Rantakallio, P., Hartikainen, A. L., Isohanni, M., & Sipila, P. (1998). Schizophrenia as a long-term outcome of pregnancy, delivery, and perinatal complications: A 28-year follow-up of the 1966 north Finland general population birth cohort. American Journal of Psychiatry, 155, 355–364.

Jorgensen, P. (1998). Early signs of psychotic relapse in schizophrenia. British Journal of Psychiatry, 172, 327–330.

Kagan, J., Reznick, J. S., & Snidman, N. (1988). Biological bases of childhood shyness. Science, 240, 167–171.

Kandel, E. R. (1999). Biology and the future of psychoanalysis: A new intellectual framework for psychiatry revisited. American Journal of Psychiatry, 156, 505–524.

Kane, J. M. (1985). Antipsychotic drug side effects: Their relationship to dose. Journal of Clinical Psychiatry, 46, 16–21.

Kane, J. M. (1989). The current status of neuroleptic therapy. Journal of Clinical Psychiatry, 50, 322–328.

Kane, J. M. (1992). New developments in the pharmacological treatment of schizophrenia. Bulletin of the Menninger Clinic, 56, 62–75.

Kane, J. M. (1996). Treatment-resistant schizophrenic patients. Journal of Clinical Psychiatry, 57(Suppl. 9), 35–40.

Kane, J. M. (1997). What are the therapeutic needs in schizophrenia and how are they satisfied by new antipsychotics? International Clinical Psychopharmacology, 12(Suppl. 2), S3–S6.

Kane, J. M., & Marder, S. R. (1993). Psychopharmacologic treatment of schizophrenia. Schizophrenia Bulletin, 19, 287–302.

Kane, J. M., & McGlashan, T. H. (1995). Treatment of schizophrenia. Lancet, 346, 820–825.

Kapur, S., & Mann, J. J. (1992). Role of the dopaminergic system in depression. Biological Psychiatry, 32, 1–17.

Kapur, S., Mieczkowski, T., & Mann, J. J. (1992). Antidepressant medications and the relative risk of suicide attempt and suicide. Journal of the American Medical Association, 268, 3441–3445.

Katon, W. (1996). The impact of major depression on chronic medical illness. General Hospital Psychiatry, 18, 215–219.

Katon, W. J. (1995). Will improving detection of depression in primary care lead to improved depressive outcomes? General Hospital Psychiatry, 17, 1–2.

Katon, W., von Korff, M., Lin, E., Bush, T., & Ormel, J. (1992). Adequacy and duration of antidepressant treatment in primary care. Medical Care, 30, 67–76.

Katon, W., Von Korff, M., Lin, E., Unutzer, J., Simon, G., Walker, E., Ludman, E., & Bush, T. (1997). Population-based care of depression: Effective disease management strategies to decrease prevalence. General Hospital Psychiatry, 19, 169–178.

Kaufmann, C. L. (1995). The self-help employment center. Some outcomes from the first year. Psychosocial Rehabilitation Journal, 18, 145–162.

Kaufmann, C. L., Ward-Colasante, C., & Farmer, J. (1993). Development and evaluation of drop-in centers operated by mental health consumers. Hospital and Community Psychiatry, 44, 675–678.

Keller, M. B., & Hanks, D. L. (1994). The natural history and heterogeneity of depressive disorders: Implications for rational antidepressant therapy. Journal of Clinical Psychiatry, 55(Suppl. A), 25–31.

Keller, M. B., Lavori, P. W., Kane, J. M., Gelenberg, A. J., Rosenbaum, J. F., Walzer, E. A., & Baker, L. A. (1992). Subsyndromal symptoms in bipolar disorder. A comparison of standard and low serum levels of lithium. Archives of General Psychiatry, 49, 371–376.

Keller, M. B., & Shapiro, R. W. (1982). "Double depression": Superimposition of acute depressive episodes on chronic depressive disorders. American Journal of Psychiatry, 139, 438–442.

Kendler, K. S., & Diehl, S. R. (1993). The genetics of schizophrenia: A current, genetic-epidemiologic perspective. Schizophrenia Bulletin, 19, 261–285.

Kendler, K. S., Heath, A. C., Martin, N. G., & Eaves, L. J. (1987). Symptoms of anxiety and symptoms of depression. Same genes, different environments? Archives of General Psychiatry, 44, 451–457.

Kendler, K. S., Kessler, R. C., Walters, E. E., MacLean, C., Neale, M. C., Heath, A. C., & Eaves, L. J. (1995). Stressful life events, genetic liability, and onset of an episode of major depression in women. American Journal of Psychiatry, 152, 833–842.

Kendler, K. S., MacLean, C. J., O'Neill, F. A., Burke, J., Murphy, B., Duke, F., Shinkwin, R., Easter, S. M., Webb, B. T., Zhang, J., Walsh, D., & Straub, R. E. (1996). Evidence for a schizophrenia vulnerability locus on chromosome 8p in the Irish study of high-density schizophrenia families. American Journal of Psychiatry, 153, 1534–1540.

Kent, J. M., Coplan, J. D., & Gorman, J. M. (1998). Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety. Biological Psychiatry, 44, 812–824.

Keri, S., Szekeres, G., Kelemen, O., Antal, A., Szendi, I., Kovacs, Z., Benedek, G., & Janka, Z. (1998). Abstraction is impaired at the perceptual level in schizophrenic patients. Neuroscience Letters, 243, 93–96.

Kern, R. S., Green, M. F., Marshall, B. D., Jr., Wirshing, W. C., Wirshing, D., McGurk, S., Marder, S. R., & Mintz, J. (1998). Risperidone vs. haloperidol on reaction time, manual dexterity, and motor learning in treatment-resistant schizophrenia patients. Biological Psychiatry, 44, 726–732.

Kessler, R. C., McGonagle, K. A., Zhao, S., Nelson, C. B., Hughes, M., Eshleman, S., Wittchen, H. U., & Kendler, K. S. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry, 51, 8–19.

Kessler, R. C., Sonnega, A., Bromet, E., Hughes, M., & Nelson, C. B. (1995). Posttraumatic stress disorder in the National Comorbidity Survey. Archives of General Psychiatry, 52, 1048–1060.

Kety, S. S. (1987). The significance of genetic factors in the etiology of schizophrenia: Results from the national study of adoptees in Denmark. Journal of Psychiatric Research, 21, 423–429.

Kiev, A., Masco, H. L., Wenger, T. L., Johnston, J. A., Batey, S. R., & Holloman, L. C. (1994). The cardiovascular effects of bupropion and nortriptyline in depressed outpatients. Annals of Clinical Psychiatry, 6, 107–115.

Kim, K., & Jacobs, S. (1995). Stress of bereavement and consequent psychiatric illness. In C. M. Maure (Ed.), Does stress cause psychiatric illness? (pp. 187–219). Washington, DC: American Psychiatric Press.

Kirchner, J. E., Owen, R. R., Nordquist, C., & Fischer, E. P. (1998). Diagnosis and management of substance use disorders among inpatients with schizophrenia. Psychiatric Services, 49, 82–85.

Kirkpatrick, B., Ram, R., Amador, X. F., Buchanan, R. W., McGlashan, T., Tohen, M., & Bromet, E. (1998). Summer birth and the deficit syndrome of schizophrenia. American Journal of Psychiatry, 155, 1221–1226.

Klein, D. F., & Ross, D. C. (1993). Reanalysis of the National Institute of Mental Health Treatment of Depression Collaborative Research Program General Effectiveness Report. Neuropsychopharmacology, 8, 241–251.

Klerman, G. L. (1990). The psychiatric patient's right to effective treatment: Implications of Osheroff v. Chestnut Lodge. American Journal of Psychiatry, 147, 409–418.

Klerman, G. L., Weissman, M. M., Ouellette, R., Johnson, J., & Greenwald, S. (1991). Panic attacks in the community. Social morbidity and health care utilization. Journal of the American Medical Association, 265, 742–746.

Klerman, G. L., Weissman, M. M., Rounsaville, B. J., & Sherron, E. S. (1984). Interpersonal psychotherapy of depression. New York: Basic Books.

Klosterkotter, J., Albers, M., Steinmeyer, E. M., Hensen, A., & Sass, H. (1995). Positive or negative symptoms—which are more appropriate as diagnostic criteria for schizophrenia? Acta Psychiatrica Scandinavica, 92, 321–326.

Kopelowicz, A., Liberman, R. P., Mintz, J., & Zarate, R. (1997). Comparison of efficacy of social skills training for deficit and nondeficit negative symptoms in schizophrenia. American Journal of Psychiatry, 154, 424–425.

Kornstein, S. G., Schatzberg, A. F., Thase, M. E., Yonkers, K. A., McCullough, J. P., Keitner, G. I., Gelenberg, A. J., Davis, S. M., Harrison, W. M., & Keller, M. B. (in press). Gender differences in treatment response to sertraline versus imipramine in chronic depression. American Journal of Psychiatry.

Kosten, T. R., & Ziedonis, D. M. (1997). Substance abuse and schizophrenia: Editors' introduction. Schizophrenia Bulletin, 23, 181–186.

Kovacs, M., Rush, A. J., Beck, A. T., & Hollon, S. D. (1981). Depressed outpatients treated with cognitive therapy or pharmacotherapy. A one-year follow-up. Archives of General Psychiatry, 38, 33–39.

Krieger, N., Rowley, D. L., Herman, A. A., Avery, B., & Phillips, M. T. (1993). Racism, sexism, and social class: Implications for studies of health, disease, and well-being. American Journal of Preventive Medicine, 9(Suppl.), 82–122.

Kukopulos, A., Reginaldi, D., Laddomada, P., Floris, G., Serra, G., & Tondo, L. (1980). Course of the manic-depressive cycle and changes caused by treatment. Pharmakopsychiatrie Neuro-Psychopharmakologie, 13, 156–167.

Kunugi, H., Takei, N., Saito, K., Akizuki, S., Murray, R. M., & Nanko, S. (1996). Relationship between impairment of prenatal brain growth and family history of psychosis in schizophrenia. Journal of Psychiatric Research, 30, 475–481.

Kunugi, H., Vallada, H., Sham, P., Hoda, F., Arranz, M., Li, T., Nanko, S., Murray, R. M., McGuffin, P., Owen, M., Gill, M., & Collier, D. (1997). Catechol-O-methyltransferase polymorphisms and schizophrenia: A transmission disequilibrium study in multiply affected families. Psychiatric Genetics, 7, 97–101.

Kupfer, D. J. (1991). Long-term treatment of depression. Journal of Clinical Psychiatry, 52(Suppl.), 28–34.

Kupfer, D. J., Frank, E., McEachran, A. B., & Grochocinski, V. J. (1990). Delta sleep ratio. A biological correlate of early recurrence in unipolar affective disorder. Archives of General Psychiatry, 47, 1100–1105.

Kupfer, D. J., Frank, E., Perel, J. M., Cornes, C., Mallinger, A. G., Thase, M. E., McEachran, A. B., & Grochocinski, V. J. (1992). Five-year outcome for maintenance therapies in recurrent depression. Archives of General Psychiatry, 49, 769–773.

Kurtz, L. F. (1997). Self-help and support groups: A handbook for practitioners. Thousand Oaks, CA: Sage Publications.

Lam, D. H. (1991). Psychosocial family intervention in schizophrenia: A review of empirical studies. Psychological Medicine, 21, 423–441.

Lam, Y. W., Jann, M. W., Chang, W. H., Yu, H. S., Lin, S. K., Chen, H., & Davis, C. M. (1995). Intra- and interethnic variability in reduced haloperidol to haloperidol ratios. Journal of Clinical Pharmacology, 35, 128–136.

Lamarque, V. (1996). [Hematologic effects of clozapine: A review of the international experience]. Encephale, 22(6), 35–36.

Lamb, H. R., & Weinberger, L. E. (1998). Persons with severe mental illness in jails and prisons: A review. Psychiatric Services, 49, 483–492.

Lawson, W. B., Helpler, N., Holladay, J., & Cuffel, B. (1994). Race as a factor in inpatient and outpatient admissions and diagnosis. Hospital Community Psychiatry, 45, 72–74.

Lazarus, R. S., & Folkman, S. (1984). Stress, appraisal and coping. New York: Springer.

LeDoux, J. (1996). Emotional networks and motor control: A fearful view. Progress in Brain Research, 107, 437–446.

Lehman, A. F. (1995). Vocational rehabilitation in schizophrenia. Schizophrenia Bulletin, 21, 645–656.

Lehman, A. F. (1996). Evaluating outcomes of treatments for persons with psychotic disorders. Journal of Clinical Psychiatry, 57(Suppl. 11), 61–67.

Lehman, A. F. (1997). Managing schizophrenia: Interventions and outcomes. Disease Management and Health Outcomes, 1, 286–295.

Lehman, A. F. (1998). Public health policy, community services, and outcomes for patients with schizophrenia. Psychiatric Clinics of North America, 21, 221–231.

Lehman, A. F., & Newman, S. J. (1996). Housing. In W. R. Breakey (Ed.), Integrated mental health services: Modern community psychiatry (pp. 300–309). New York: Oxford University Press.

Lehman, A. F., Postrado, L. T., Roth, D., McNary, S., & Goldman, H. (1994). An evaluation of continuity of care, case management, and client outcomes in the RWJ PCMI. Milbank Quarterly, 72, 105–122.

Lehman, A. F., & Steinwachs, D. M. (1998a). Patterns of usual care for schizophrenia: Initial results from the Schizophrenia Patient Outcomes Research Team (PORT) Client Survey. Schizophrenia Bulletin, 24, 11–20.

Lehman, A. F., & Steinwachs, D. M. (1998b). Translating research into practice: The Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophrenia Bulletin, 24, 1–10.

Lenox, R. H., Newhouse, P. A., Creelman, W. L., & Whitaker, T. M. (1992). Adjunctive treatment of manic agitation with lorazepam versus halperidol: A double-blind study. Journal of Clinical Psychiatry, 53, 47–52.

Lerer, B., Moore, N., Meyendorff, E., Cho, S. R., & Gershon, S. (1987). Carbamazepine versus lithium in mania: A double-blind study. Journal of Clinical Psychiatry, 48, 89–93.

Levey, S., Howells, K., & Cowden, E. (1995). Dangerousness, unpredictability, and the fear of people with schizophrenia. Journal of Forensic Psychiatry, 6, 19–39.

Levin, S., Yurgelun-Todd, D., & Craft, S. (1989). Contribution of clinical neuropsychology to the study of schizophrenia. Journal of Abnormal Psychology, 98, 341–356.

Levinson, D. F., Mahtani, M. M., Nancarrow, D. J., Brown, D. M., Kruglyak, L., Kirby, A., Hayward, N. K., Crowe, R. R., Andreasen, N. C., Black, D. W., Silverman, J. M., Endicott, J., Sharpe, L., Mohs, R. C., Siever, L. J., Walters, M. K., Lennon, D. P., Jones, H. L., Nertney, D. A., Daly, M. J., Gladis, M., & Mowry, B. J. (1998). Genome scan of schizophrenia. American Journal of Psychiatry, 155, 741–750.

Levinson, D. F., Simpson, G. M., Singh, H., Yadalam, K., Jain, A., Stephanos, M. J., & Silver, P. (1990). Fluphenazine dose, clinical response, and extrapyramidal symptoms during acute treatment. Archives of General Psychiatry, 47, 761–768.

Lewis, P., Rack, P. H., Vaddadi, K. S., & Allen, J. J. (1980). Ethnic differences in drug response. Postgraduate Medical Journal, 56(Suppl. 1), 46–49.

Ley, A., Jeffery, D. P., McLaren, S., & Siegfried, N. (1999). Treatment programmes for those with both severe mental illness and substance misuse (Cochrane Review). In The Cochrane Library, Issue 4. Oxford, U.K.: Update Software.

Liberman, R. P., Wallace, C. J., Blackwell, G., Kopelowicz, A., Vaccaro, J. V., & Mintz, J. (1998). Skills training versus psychosocial occupational therapy for persons with persistent schizophrenia. American Journal of Psychiatry, 155, 1087–1091.

Liberman, R. P., Wallace, C. J., Vaughn, C. E., Snyder, K. S., & Rust, C. (1980). Social and family factors in the course of schizophrenia: Toward an interpersonal problem-solving therapy for schizophrenics and their relatives. In J. Strauss, S. Fleck, & M. Bowers (Eds.), Psychotherapy of schizophrenia: Current status and new directions (pp. 21–54). New York: Plenum Publishing.

Lieberman, A. A., Gowdy, E. A., & Knutson, L. C. (1991). The mental health outreach project: A case study in self-help. Psychosocial Rehabilitation Journal, 14, 100–105.

Lieberman, J. A. (1993). Understanding the mechanism of action of atypical antipsychotic drugs. A review of compounds in use and development. British Journal of Psychiatry. Supplement, 22, 7–18.

Lieberman, J. A. (1996). Atypical antipsychotic drugs as a first-line treatment of schizophrenia: A rationale and hypothesis. Journal of Clinical Psychiatry, 57(Suppl. 11), 68–71.

Lieberman, J., Jody, D., Geisler, S., Alvir, J., Loebel, A., Szymanski, S., Woerner, M., & Borenstein, M. (1993). Time course and biologic correlates of treatment response in first- episode schizophrenia. Archives of General Psychiatry, 50, 369–376.

Lieberman, J. A., Koreen, A. R., Chakos, M., Sheitman, B., Woerner, M., Alvir, J. M., & Bilder, R. (1996). Factors influencing treatment response and outcome of first-episode schizophrenia: Implications for understanding the pathophysiology of schizophrenia. Journal of Clinical Psychiatry, 57(Suppl. 9), 5–9.

Lieberman, J. A., Safferman, A. Z., Pollack, S., Szymanski, S., Johns, C., Howard, A., Kronig, M., Bookstein, P., & Kane, J. M. (1994). Clinical effects of clozapine in chronic schizophrenia: Response to treatment and predictors of outcome. American Journal of Psychiatry, 151, 1744–1752.

Liebowitz, M. R. (1997). Panic disorder as a chronic illness. Journal of Clinical Psychiatry, 58(Suppl. 13), 5–8.

Lin, K. M., Anderson, D., & Poland, R. E. (1995). Ethnicity and psychopharmacology. Bridging the gap. Psychiatric Clinics of North America, 18, 635–647.

Lin, K. M., Anderson, D., & Poland, R. E. (1997). Ethnic and cultural considerations in psychopharmacotherapy. In D. Dunner (Ed.), Current psychiatric therapy (2nd ed., pp. 75–81). Philadelphia: W. B. Saunders.

Linde, K., Ramirez, G., Mulrow, C. D., Pauls, A., Weidenhammer, W., & Melchart, D. (1996). St. John’s wort for depression—an overview and meta-analysis of randomised clinical trials. British Medical Journal, 313, 253–258.

Lipska, B. K., Swerdlow, N. R., Geyer, M. A., Jaskiw, G. E., Braff, D. L., & Weinberger, D. R. (1995). Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology, 122, 35–43.

Lipska, B. K., & Weinberger, D. R. (1993). Delayed effects of neonatal hippocampal damage on haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat. Brain Research, Developmental Brain Research, 75, 213–222.

Lipska, B. K., & Weinberger, D. R. (1997). Animal models of schizophrenia. Unpublished manuscript.

Loebel, A. D., Botts, S. R., & Feldman, B. I. (1998). Atypical antipsychotics in the managed care era. American Journal of Managed Care, 4, S37–S59.

Long, L., & Van Tosh, L. (1988). Program descriptions of consumer-run programs for homeless people with mental illness. Rockville, MD: National Institute of Mental Health.

Lopez, S. R., Nelson, K., Snyder, K., & Mintz, J. (in press). Attributions and affective reactions of family members and course of schizophrenia. Journal of Abnormal Psychology.

Loyd, D. W., & Tsuang, M. T. (1985). Disability and welfare—who wants it? Journal of Clinical Psychiatry, 46, 273–275.

Lu, F. G., Lim, R. F., & Mezzich, J. E. (1995). Issues in the assessment and diagnosis of culturally diverse individuals. In J. Olham & M. Riba (Eds.), Review of psychiatry (Vol. 14, pp. 477–509). Washington, DC: American Psychiatric Press.

Luke, D. A. (1989). The measurement of change in a self- help context. Unpublished doctoral dissertation, University of Illinois, Urbana-Champaign.

Lydiard, R. B., Brawman-Mintzer, O., & Ballenger, J. C. (1996). Recent developments in the psychopharmacology of anxiety disorders. Journal of Consulting and Clinical Psychology, 64, 660–668.

Lynch, M. D., & Kruzich, J. M. (1986). Needs assessment of the chronically mentally ill: Practitioner and client perspectives. Administration in Mental Health, 4, 237–248.

Maciejewski, P. W., Prigerson, H. G., & Mazure, C. M. (1999). Sex differences in event-related risk for major depression. Manuscript submitted for publication.

MacMillan, H. L., Fleming, J. E., Trocme, N., Boyle, M. H., Wong, M., Racine, Y. A., Beardslee, W. R., & Offord, D. R. (1997). Prevalence of child physical and sexual abuse in the community. Results from the Ontario Health Supplement. Journal of the American Medical Association, 278, 131–135.

Magee, W. J., Eaton, W. W., Wittchen, H. U., McGonagle, K. A., & Kessler, R. C. (1996). Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Archives of General Psychiatry, 53, 159–168.

Mahurin, R. K., Velligan, D. I., & Miller, A. L. (1998). Executive-frontal lobe cognitive dysfunction in schizophrenia: A symptom subtype analysis. Psychiatry Research, 79, 139–149.

Mancuso, L. (1990). Reasonable accommodation for workers with psychiatric disabilities. Psychosocial Rehabilitation Journal, 2, 3–19.

March, J. S., Frances, A., Carpenter, D., & Kahn, D. A. (1997). Treatment of obsessive-compulsive disorder. The Expert Consensus Panel for obsessive-compulsive disorder. Journal of Clinical Psychiatry, 58, 2–72.

Marcus, S. C., Olfson, M., Pincus, H. A., Shear, M. K., & Zarin, D. A. (1997). Self-reported anxiety, general medical conditions, and disability bed days. American Journal of Psychiatry, 154, 1766–1768.

Marder, S. R., Wirshing, W. C., Mintz, J., McKenzie, J., Johnston, K., Eckman, T. A., Lebell, M., Zimmerman, K., & Liberman, R. P. (1996). Two-year outcome of social skills training and group psychotherapy for outpatients with schizophrenia. American Journal of Psychiatry, 153, 1585–1592.

Mari, J. J., & Streiner, D. L. (1994). An overview of family interventions and relapse on schizophrenia: Meta-analysis of research findings. Psychological Medicine, 24, 565–578.

Marks, I. M. (1969). Fears and phobias. New York: Academic Press.

Maslowski, J., Jansen van Rensburg, D., & Mthoko, N. (1998). A polydiagnostic approach to the differences in the symptoms of schizophrenia in different cultural and ethnic populations. Acta Psychiatrica Scandinavica, 98, 41–46.

Mason, P., Harrison, G., Croudace, T., Glazebrook, C., & Medley, I. (1997). The predictive validity of a diagnosis of schizophrenia. A report from the International Study of Schizophrenia (ISoS) coordinated by the World Health Organization and the Department of Psychiatry, University of Nottingham. British Journal of Psychiatry, 170, 321–327.

Mattson, D. T., Berk, M., & Lucas, M. D. (1997). A neuropsychological study of prefrontal lobe function in the positive and negative subtypes of schizophrenia. Journal of Genetic Psychology, 158, 487–494.

Maziade, M., Bouchard, S., Gingras, N., Charron, L., Cardinal, A., Roy, M. A., Gauthier, B., Tremblay, G., Cote, S., Fournier, C., Boutin, P., Hamel, M., Merette, C., & Martinez, M. (1996). Long-term stability of diagnosis and symptom dimensions in a systematic sample of patients with onset of schizophrenia in childhood and early adolescence. II: Postnegative distinction and childhood predictors of adult outcome. British Journal of Psychiatry, 169, 371–378.

McCarthy, J., & Nelson, G. (1991). An evaluation of supportive housing for current and former psychiatric patients. Hospital and Community Psychiatry, 42, 1254–1256.

McElroy, S. L., Keck, P. E., Jr., Pope, H. G., Jr., & Hudson, J. I. (1992). Valproate in the treatment of bipolar disorder: Literature review and clinical guidelines. Journal of Clinical Psychopharmacology, 12, 42S–52S.

McEwen, B. S. (1998). Protective and damaging effects of stress mediators. New England Journal of Medicine, 338, 171B179.

McEwen, B. S., & Magarinos, A. M. (1997). Stress effects on morphology and function of the hippocampus. Annals of the New York Academy of Sciences, 821, 271–284.

McFarlane, A. C., & Yehuda, R. (1996). Resilience, vulnerablity, and the course of post-traumatic reactions. In B. A. van der Kolk, A. C. McFarlane, & L. Weisath (Eds.), Traumatic stress: The effects of overwhelming experience on mind, body and society (pp. 155–181). New York: Guilford Press.

McFarlane, W. R. (1997). Family psychoeducation: Basic concepts and innovative applications. In S. W. Henggeler & A. B. Santos (Eds.), Innovative approaches for difficult-to-treat populations (pp. 211–238). Washington, DC: American Psychiatric Press.

McFarlane, W. R., Lukens, E., Link, B., Dushay, R., Deakins, S. A., Newmark, M., Dunne, E. J., Horen, B., & Toran, J. (1995). Multiple-family groups and psychoeducation in the treatment of schizophrenia. Archives of General Psychiatry, 52, 679–687.

McGuffin, P., Owen, M. J., & Farmer, A. E. (1995). Genetic basis of schizophrenia. Lancet, 346, 678–682.

McGuire, P. K., Quested, D. J., Spence, S. A., Murray, R. M., Frith, C. D., & Liddle, P. F. (1998). Pathophysiology of “positive” thought disorder in schizophrenia. British Journal of Psychiatry, 173, 231–235.

McInnis, M. G., McMahon, F. J., Chase, G. A., Simpson, S. G., Ross, C. A., & DePaulo, J. R. (1993). Anticipation in bipolar affective disorder. American Journal of Human Genetics, 53, 385–390.

McLeod, J. D., & Kessler, R. C. (1990). Socioeconomic status differences in vulnerability to undesirable life events. Journal of Health and Social Behavior, 31, 162–172.

Mead, S. (1997). Stepping stone crisis respite program. NEC Newsletter, 10.

Mechanic, D. (1998). Cultural and organizational aspects of application of the Americans With Disabilities Act to persons with psychiatric disabilities. Milbank Quarterly, 76, 5–23.

Medalia, A., Aluma, M., Tryon, W., & Merriam, A. E. (1998). Effectiveness of attention training in schizophrenia. Schizophrenia Bulletin, 24, 147–152.

Mednick, S. A., Machon, R. A., Huttunen, M. O., & Bonett, D. (1988). Adult schizophrenia following prenatal exposure to an influenza epidemic. Archives of General Psychiatry, 45, 189–192.

Meltzer, H. Y. (1997). Treatment-resistant schizophrenia—The role of clozapine. Current Medical Research Opinion, 14, 1–20.

Mendlewicz, J., & Rainer, J. D. (1977). Adoption study supporting genetic transmission in manic-depressive illness. Nature, 268, 327–329.

Meredith, L. S., Wells, K. B., & Camp, P. (1994). Clinician specialty and treatment style for depressed outpatients with and without medical comorbidities. Archives of Family Medicine, 3, 1065–1072.

Meredith, L. S., Wells, K. B., Kaplan, S. H., & Mazel, R. M. (1996). Counseling typically provided for depression. Role of clinician specialty and payment system. Archives of General Psychiatry, 53, 905–912.

Merikangas, K. R., Mehta, R. L., Molnar, B. E., Walters, E. E., Swendsen, J. D., Aguilar-Gaziola, S., Bijl, R., Borges, G., Caraveo-Anduaga, J. J., Dewit, D. J., Kolody, B., Vega, W. A., Wittchen, H. U., & Kessler, R. C. (1998). Comorbidity of substance use disorders with mood and anxiety disorders: Results of the international consortium in psychiatric epidemiology. Addictive Behaviors, 23, 893–907.

Meterissian, G. B., & Bradwejn, J. (1989). Comparative studies on the efficacy of psychotherapy, pharmacotherapy, and their combination in depression: Was adequate pharmacotherapy provided? Journal of Clinical Psychopharmacology, 9, 334–339.

Miller, D. D. (1996). Schizophrenia: Its etiology and impact. Pharmacotherapy, 16, 2–5.

Miller, I. W., Norman, W. H., & Keitner, G. I. (1990). Treatment response of high cognitive dysfunction depressed inpatients. Comprehensive Psychiatry, 31, 62–71.

Miller, L., & Miller, L. (1997). A.N.G.E.L.S., Inc.: A consumer-run supported employment agency. Psychiatric Rehabilitation Journal, 21, 160–163.

Miner, C. R., Rosenthal, R. N., Hellerstein, D. J., & Muenz, L. R. (1997). Prediction of compliance with outpatient referral in patients with schizophrenia and psychoactive substance use disorders. Archives of General Psychiatry, 54, 706–712.

Miranda, J., Azocar, F., Komaromy, M., & Golding, J. M. (1998). Unmet mental health needs of women in public-sector gynecologic clinics. American Journal of Obstetrics and Gynecology, 178, 212–217.

Miranda, J., & Green, B. L. (1999). The need for mental health services research focusing on poor young women. Journal of Mental Health Policy and Economics, 2, 73–89.

Mischel, W., & Shoda, Y. (1998). Reconciling processing dynamics and personality dispositions. Annual Review of Psychology, 49, 229–258.

Mitchell, A. J. (1998). The role of corticotropin releasing factor in depressive illness: A critical review. Neuroscience and Biobehavioral Reviews, 22, 635–651.

Moller, H. J., & von Zerssen, D. (1995). Course and outcome of schizophrenia. In S. R. Hirsch & D. R. Weinberger (Eds.), Schizophrenia (pp. 106–127). London: Blackwell Science.

Monking, H. S. (1994). Self-help groups for families of schizophrenia patients. Social Psychiatry and Psychiatry Epidemiology, 29, 149–154.

Montgomery, S. A., Dufour, H., Brion, S., Gailledreau, J., Laqueille, X., Ferrey, G., Moron, P., Parant-Lucena, N., Singer, L., Danion, J. M., Beuzen, J. N., & Pierredon, M. A. (1988). The prophylactic efficacy of fluoxetine in unipolar depression. British Journal of Psychiatry. Supplement, 69–76.

Morrissey, J., Calloway, M., Bartko, T., Ridgely, M. S., Goldman, H., & Paulson, R. (1994). Mental health authorities and service system change from the RWJ PCMI. Milbank Quarterly, 72, 49–80.

Mosher, L. R. (1999). Soteria and other alternatives to acute psychiatric hospitalization: A personal and professional review. Journal of Nervous and Mental Disease, 187, 142–149.

Mosher, L. R., & Menn, A. (1978). Community residential treatment for schizophrenia: Two year follow-up. Hospital and Community Psychiatry, 29, 715–723.

Mowbray, C. T., Leff, S., Warren, R., McCrohan, N. M., & Bybee, D. (1997). Enhancing vocational outcomes for persons with psychiatric disabilities: A new paradigm. In S. W. Henggeler & A. B. Santos (Eds.), Innovative approaches for difficult-to-treat populations (pp. 311–350). Washington, DC: American Psychiatric Press.

Mowbray, C. T., Moxley, D. P., Thrasher, S., Bybee, D., McCrohan, N., Harris, S., & Clover, G. (1996). Consumers as community support providers: Issues created by role innovation. Community Mental Health Journal, 32, 47–67.

Mowbray, C. T., Solomon, M., Ribisl, K. M., Ebejer, M. A., Deiz, N., Brown, W., Bandla, H., Luke, D. A., Davidson, W. S., Jr.,, & Herman, S. (1995). Treatment for mental illness and substance abuse in a public psychiatric hospital. Successful strategies and challenging problems. Journal of Substance Abuse Treatment, 12, 129–139.

Mowbray, C. T., & Tan, C. (1993). Consumer-operated drop-in centers: Evaluation of operations and impact. Journal of Mental Health Administration, 20, 8–19.

Mueser, K. T., Bond, G. R., Drake, R. E., & Resnick, S. G. (1998a). Models of community care for severe mental illness: A review of research on case management. Schizophrenia Bulletin, 24, 37–74.

Mueser, K. T., Drake R. D., & Miles K. M. (1997a). The course and treatment of substance use disorders in persons with severe mental illnesses. NIDA Research Monograph, 172, 86–109.

Mueser, K. T., Drake, R. E., & Bond, G. R. (1997b). Recent advances in psychiatric rehabilitation for patients with severe mental illness. Harvard Review of Psychiatry, 5, 123–137.

Mueser, K. T., Drake, R. E., & Wallach, M. A. (1998b). Dual diagnosis: A review of etiological theories. Addictive Behaviors, 23, 717–734.

Mueser, K. T., Yarnold, P. R., Levinson, D. F., Singh, H., Bellack, A. S., Kee, K., Morrison, R. L., & Yadalam, K. G. (1990). Prevalence of substance abuse in schizophrenia: Demographic and clinical correlates. Schizophrenia Bulletin, 16, 31–56.

---

Back to Top

Home | Contents | Previous | Next